Preferred Label : risk management;

MeSH definition : The process of minimizing risk to an organization by developing systems to identify and analyze potential hazards to prevent accidents, injuries, and other adverse occurrences, and by attempting to handle events and incidents which do occur in such a manner that their effect and cost are minimized. Effective risk management has its greatest benefits in application to insurance in order to avert or minimize financial liability. (From Slee & Slee: Health care terms, 2d ed);

MeSH synonym : management, risks; management, risk; risks management;

CISMeF synonym : management risk; management risks; managements, risks; risk, management; risks managements; risks, management;

MeSH hyponym : Incident Reporting; reporting, hospital incident; Reportings, Hospital Incident; Reportings, Hospital Risk; Hospital Risk Reporting; Hospital Risk Reportings; Reporting, Hospital Risk; Risk Reporting, Hospital; Risk Reportings, Hospital; Incident Reportings, Hospital; Incident Reporting, Hospital; Hospital Incident Reportings; Voluntary Patient Safety Event Reporting; Hospital Incident Reporting; Incident Reportings; Reporting, Incident; Reportings, Incident;

Wikipedia link : https://en.wikipedia.org/wiki/Risk management;

Details


Main resources

You can consult :

The process of minimizing risk to an organization by developing systems to identify and analyze potential hazards to prevent accidents, injuries, and other adverse occurrences, and by attempting to handle events and incidents which do occur in such a manner that their effect and cost are minimized. Effective risk management has its greatest benefits in application to insurance in order to avert or minimize financial liability. (From Slee & Slee: Health care terms, 2d ed)

https://ansm.sante.fr/tableau-marr/pirfenidone
2024
false
false
false
France
French
guidelines for drug use
risk management
pirfenidone
pirfenidone
administration, oral
patient education handout
photosensitization
Drug-induced photosensitivity (disorder)
pirfenidone
Chemical and Drug Induced Liver Injury
continuity of patient care
liver function tests
Drug-Related side effects and adverse reactions

---
https://ansm.sante.fr/tableau-marr/ponesimod
2024
false
false
false
France
French
risk management
ponesimod
ponesimod
administration, oral
ponesimod
ponvory
guidelines for drug use
patients guideline
pregnancy
continuity of patient care
ponesimod
adult
multiple sclerosis, relapsing-remitting
drug monitoring
immunosuppressive agents
immunosuppressive agents
immunosuppressive agents

---
https://ansm.sante.fr/tableau-marr/inhibiteur-de-la-c1-esterase-humaine
2024
false
false
false
France
French
risk management
guidelines for drug use
continuity of patient care
Human C1-Esterase Inhibitor
patients guideline

---
https://ansm.sante.fr/tableau-marr/elranatamab
2024
false
false
false
France
French
risk management
Elranatamab
drug information
patients guideline
Cytokine Release Syndrome
nervous system diseases

---
https://ansm.sante.fr/tableau-marr/susoctocog-alfa
2024
false
false
false
France
French
risk management
Susoctocog Alfa
medication errors
guidelines for drug use
drug dosage calculations
video recording

---
https://ansm.sante.fr/tableau-marr/mecasermine
2024
false
false
false
France
French
risk management
mecasermin
mecasermin
mecasermin
Drug-Related side effects and adverse reactions
patient education handout
guidelines for drug use
mecasermin
hypoglycemia
injections, subcutaneous

---
https://ansm.sante.fr/tableau-marr/aciclovir
2024
false
false
false
France
French
guideline
patients guideline
drug information
risk management
acyclovir
Accidental Drug Ingestion
Muco-adhesive Buccal Tablet Dosage Form

---
https://ansm.sante.fr/tableau-marr/methotrexate-per-os
2024
false
false
false
France
French
guidelines for drug use
risk management
methotrexate
administration, oral
patient education handout
medication errors

---
https://ansm.sante.fr/tableau-marr/adalimumab
2024
false
false
false
France
French
Adalimumab
risk management
continuity of patient care
drug information
adult
child
patient education handout

---
https://ansm.sante.fr/tableau-marr/tocilizumab-1
2024
false
false
false
France
French
risk management
tocilizumab
infusions, intravenous
injections, subcutaneous
guidelines for drug use
tocilizumab
tocilizumab
patient education handout
continuity of patient care
tocilizumab

---
https://ansm.sante.fr/tableau-marr/sarilumab
2024
false
false
false
France
French
risk management
continuity of patient care
drug information
injections, subcutaneous
antibodies, monoclonal, humanized
sarilumab
patients guideline

---
https://ansm.sante.fr/tableau-marr/tafamidis
2024
false
false
false
France
French
risk management
tafamidis
administration, oral
guidelines for drug use
tafamidis
adult
pregnancy
breast feeding
tafamidis
Cardiac Amyloidosis
amyloidosis, hereditary, Transthyretin-Related
amyloidosis, hereditary, Transthyretin-Related

---
https://ansm.sante.fr/tableau-marr/belatacept
2024
false
false
false
France
French
guidelines for drug use
risk management
BELATACEPT
immunosuppressive agents
infusions, intravenous
belatacept
patient education handout
Infusion-Related Reaction
infusions, intravenous

---
https://ansm.sante.fr/tableau-marr/sutimlimab
2024
false
false
false
France
French
risk management
sutimlimab
guidelines for drug use
sutimlimab
antibodies, monoclonal, humanized
infusions, intravenous
Infections
Infections
meningococcal vaccines
meningococcal infections
vaccination
serious infection
patient education handout

---
https://ansm.sante.fr/tableau-marr/glucagon
2024
false
false
false
France
French
guidelines for drug use
risk management
glucagon
glucagon
administration, intranasal
patient education handout

---
https://ansm.sante.fr/tableau-marr/ritlecitinib
2024
false
false
false
France
French
risk management
Ritlecitinib
Drug-Related side effects and adverse reactions
ritlecitinib
guidelines for drug use
patient education handout
administration, oral
Janus Kinase Inhibitors
Immunomodulating Agents

---
https://ansm.sante.fr/tableau-marr/dronedarone
2024
false
false
false
France
French
risk management
continuity of patient care
Dronedarone
Dronedarone
dronedarone
administration, oral
guidelines for drug use
patient education handout
atrial fibrillation
Persistent Atrial Fibrillation
Paroxysmal Atrial Fibrillation
anti-arrhythmia agents
anti-arrhythmia agents

---
https://ansm.sante.fr/tableau-marr/crizotinib
2024
false
false
false
France
French
patients guideline
patient education handout
drug information
risk management
Crizotinib
Crizotinib
continuity of patient care
crizotinib
vision disorders
adult
child

---
https://ansm.sante.fr/tableau-marr/darvadstrocel
2024
false
false
false
France
French
risk management
Darvadstrocel
darvadstrocel
guidelines for drug use
guideline
medication errors
Darvadstrocel
drug storage
Infections
cold chain
temperature recording

---
https://www.cbip.be/fr/articles/4315?folia=4305
2024
false
false
false
Belgium
French
Dutch
journal article
colchicine
risk
risk management
Narrow Therapeutic Index
narrow therapeutic range drugs

---
https://ansm.sante.fr/tableau-marr/natalizumab-1
2024
false
false
false
France
French
Natalizumab
risk management
Natalizumab
natalizumab
guidelines for drug use
patient education handout
continuity of patient care
Drug-Related side effects and adverse reactions
opportunistic infections
leukoencephalopathy, progressive multifocal
immunologic factors
immunologic factors
multiple sclerosis

---
https://www.cbip.be/fr/articles/4328?folia=4319
2024
false
false
false
Belgium
French
journal article
valproic acid
risk management
Exposure to anticonvulsant (event)
paternal exposure
Neurodevelopmental Disorders
child

---
https://ansm.sante.fr/tableau-marr/venetoclax
2024
false
false
false
France
French
risk management
venetoclax
venetoclax
patient education handout
tumor lysis syndrome
administration, oral
antineoplastic agents

---
https://ansm.sante.fr/tableau-marr/panobinostat
2024
false
false
false
France
French
risk management
Panobinostat
panobinostat
administration, oral
medication errors
patients guideline
patient compliance

---
https://ansm.sante.fr/tableau-marr/tacrolimus
2024
false
false
false
France
French
risk management
tacrolimus
tacrolimus
administration, oral
guidelines for drug use
patient education handout
continuity of patient care
immunosuppressive agents

---
https://ansm.sante.fr/tableau-marr/cladribine
2024
false
false
false
France
French
risk management
cladribine
administration, oral
cladribine
immunosuppressive agents
cladribine
guidelines for drug use
patients guideline
Drug-Related side effects and adverse reactions
adult
multiple sclerosis, relapsing-remitting
continuity of patient care
hematologic tests

---
https://ansm.sante.fr/tableau-marr/inebilizumab
2024
false
false
false
France
French
risk management
inebilizumab
inebilizumab
infusions, intravenous
patients guideline
product surveillance, postmarketing
patient safety
adult
neuromyelitis optica
Immunosuppression-related infectious disease (disorder)
leukoencephalopathy, progressive multifocal
virus diseases
serious infection

---
https://ansm.sante.fr/tableau-marr/leflunomide
2024
false
false
false
France
French
risk management
patients guideline
guidelines for drug use
Leflunomide
leflunomide
administration, oral
immunosuppressive agents
continuity of patient care
Drug-Related side effects and adverse reactions

---
https://ansm.sante.fr/tableau-marr/tetradecyl-sulfate-de-sodium
2024
false
false
false
France
French
risk management
guidelines for drug use
continuity of patient care
sodium tetradecyl sulfate
sclerosing solutions
sodium tetradecyl sulfate
sodium tetradecyl sulfate
injections, intravenous
sclerotherapy

---
https://ansm.sante.fr/tableau-marr/teclistamab
2024
false
false
false
France
French
popular works
drug information
Teclistamab
risk management
teclistamab

---
https://ansm.sante.fr/tableau-marr/selexipag
2024
false
false
false
France
French
risk management
Uptravi
medication errors
selexipag
patients guideline
guidelines for drug use
Wrong dose
selexipag

---
https://ansm.sante.fr/tableau-marr/dabigatran
2024
false
false
false
France
French
guidelines for drug use
risk management
Dabigatran
Dabigatran
dabigatran etexilate
administration, oral
antithrombins
antithrombins
continuity of patient care
hemorrhage
risk
adult
child

---
https://ansm.sante.fr/tableau-marr/inotersen
2024
false
false
false
France
French
risk management
Inotersen
inotersen
Drug-Related side effects and adverse reactions
patients guideline
drug information
eye diseases
glomerulonephritis
thrombocytopenia
oligonucleotides
oligodeoxyribonucleotides, antisense

---
https://ansm.sante.fr/tableau-marr/etanercept-1
2024
false
false
false
France
French
risk management
Etanercept
patients guideline
drug information
Drug-Related side effects and adverse reactions

---
https://ansm.sante.fr/tableau-marr/insuline-glargine
2024
false
false
false
France
French
Insulin Glargine
medication errors
risk management
insulin glargine
guidelines for drug use
patients guideline

---
https://ansm.sante.fr/tableau-marr/lenalidomide
2024
false
false
false
France
French
risk management
pregnancy
contraception
lenalidomide
multiple myeloma
lymphoma, mantle-cell
teratogens
continuity of patient care
drug monitoring
clinical chemistry tests
myelodysplastic syndromes
guidelines for drug use
popular works
venous thromboembolism
Tumor Flare Reaction
neoplasms
Chemical and Drug Induced Liver Injury
angiogenesis inhibitors
angiogenesis inhibitors
thalidomide
thalidomide
thalidomide
Lenalidomide
Lenalidomide

---
https://ansm.sante.fr/tableau-marr/pomalidomide
2024
false
false
false
France
French
risk management
pregnancy
contraception
teratogens
abnormalities, drug-induced
multiple myeloma
pomalidomide
continuity of patient care
Drug-Related side effects and adverse reactions
risk factors
guidelines for drug use
thrombocytopenia
neutropenia
blood cell count
thromboembolism
Infections
patient education handout
pregnancy tests
forms
thalidomide
thalidomide

---
https://ansm.sante.fr/tableau-marr/thalidomide
2024
false
false
false
France
French
risk management
thalidomide
teratogens
abnormalities, drug-induced
pregnancy
thalidomide
guideline
forms
patient education handout
continuity of patient care
Neuropathy peripheral
thromboembolism
Drug-Related side effects and adverse reactions
pregnancy tests
contraception
package leaflet

---
https://ansm.sante.fr/tableau-marr/tolvaptan
2024
false
false
false
France
French
risk management
Tolvaptan
Tolvaptan
administration, oral
tolvaptan
polycystic kidney, autosomal dominant
continuity of patient care
liver diseases
pregnancy
guidelines for drug use
patients guideline
patient education handout

---
https://ansm.sante.fr/tableau-marr/olanzapine
2024
false
false
false
France
French
guidelines for drug use
patient education handout
Olanzapine
risk management
olanzapine
injections, intramuscular
Delayed-Action preparations
Olanzapine
metabolic diseases
continuity of patient care
drug compounding
injections, intramuscular
olanzapine pamoate
olanzapine pamoate
schizophrenia
antipsychotic agents
antipsychotic agents
medication errors
Post-injection delirium sedation syndrome (finding)

---
https://ansm.sante.fr/tableau-marr/icodextrine
2024
false
false
false
France
French
risk management
guidelines for drug use
peritoneal dialysis
blood glucose self-monitoring
Icodextrin

---
https://ansm.sante.fr/tableau-marr/nalmefene
2024
false
false
false
France
French
risk management
nalmefene
nalmefene
guidelines for drug use
patient education handout
administration, oral
patient compliance
patients guideline
alcohol drinking
continuity of patient care
nalmefene
alcoholism
adult
algorithms
Psychosocial Intervention

---
https://ansm.sante.fr/tableau-marr/eculizumab-2
2024
false
false
false
France
French
risk management
eculizumab
eculizumab
eculizumab
guidelines for drug use
patient education handout
patients guideline
antibiotic prophylaxis
infusions, intravenous
Infections
sepsis
Drug-Related side effects and adverse reactions
meningococcal infections
vaccination
meningococcal vaccines

---
https://ansm.sante.fr/informations-de-securite/prise-en-charge-par-colchicine-de-la-goutte-une-nouvelle-posologie-plus-faible-et-un-message-dalerte-sur-les-boites-pour-reduire-le-risque-de-surdosage
2023
false
false
false
France
French
risk management
colchicine
colchicine
gout
guidelines for drug use
gout suppressants
gout suppressants
colchicine

---
https://ansm.sante.fr/tableau-marr/asfotase-alfa
2023
false
false
false
France
French
risk management
guidelines for drug use
asfotase alfa
asfotase alfa
self administration
patients guideline
child
injections, subcutaneous
enzyme replacement therapy
asfotase alfa
hypophosphatasia

---
https://ansm.sante.fr/tableau-marr/epcoritamab
2023
false
false
false
France
French
risk management
bispecific monoclonal antibodies
Epcoritamab
patients guideline
Cytokine Release Syndrome
signs and symptoms
Immune Effector Cell Associated Neurotoxicity Syndrome
cell-associated neurotoxicity
drug information
epcoritamab

---
https://www.has-sante.fr/jcms/p_3330409/fr/guide-methodologique-simulation-en-sante-et-gestion-des-risques
2023
France
guideline
hazardous substances
risk-taking
Guide Device
PRETEXT Stage 3
malingering
professional practice
PRETEXT Stage 2
tool, nos
risk management
Enhance
Handbook
Management Occupations
Computer Modeling
Scientific Equipment
Management
Tool
Improved
black fly, nos
methods
health
PRETEXT Stage 1
PRETEXT Stage 4
Professional Practice

---
https://dumas.ccsd.cnrs.fr/dumas-04244803
2023
France
dissertations, academic
Pharmaceutics
Management
tool, nos
Optimization
Digital
risk management
digitalis, nos
Scientific Equipment
Digitalis
drug industry
digitalis glycosides
digitalis
Management Occupations
Pharmaceutical Dosage Form
Tool

---
https://ansm.sante.fr/actualites/progestatifs-et-risque-de-meningiome-recommandations-pour-limiter-ce-risque
2023
false
false
false
France
French
guideline
guidelines for drug use
medrogestone
medrogestone
meningioma
Drug-Related side effects and adverse reactions
medroxyprogesterone acetate
medroxyprogesterone acetate
progestins
progestins
continuity of patient care
patient safety
promegestone
risk management
risk factors

---
https://ansm.sante.fr/tableau-marr/treprostinil
2023
false
false
false
France
French
risk management
Catheter related bloodstream infection (disorder)
guidelines for drug use
treprostinil
patient education handout
infusions, intravenous
Infusion Pumps

---
https://ansm.sante.fr/tableau-marr/axicabtagene-ciloleucel
2023
false
false
false
France
French
risk management
axicabtagene ciloleucel
guidelines for drug use
axicabtagene ciloleucel
Drug-Related side effects and adverse reactions
Cytokine Release Syndrome
nervous system diseases
patient education handout
signs and symptoms
axicabtagene ciloleucel
infusions, intravenous
gene therapy

---
https://ansm.sante.fr/tableau-marr/brexucabtagene-autoleucel
2023
false
false
false
France
French
risk management
brexucabtagene autoleucel
genetic therapy
gene therapy
Cytokine Release Syndrome
signs and symptoms
guidelines for drug use
patient education handout
Drug-Related side effects and adverse reactions
nervous system diseases
brexucabtagene autoleucel
brexucabtagene autoleucel

---
https://ansm.sante.fr/tableau-acces-derogatoire/oxbryta-voxelotor
2023
false
false
false
France
French
risk management
voxelotor
voxelotor
administration, oral
hematologic agents
drug information
anemia, hemolytic
anemia, sickle cell

---
https://ansm.sante.fr/tableau-marr/abrocitinib
2023
false
false
false
France
French
risk management
abrocitinib
abrocitinib
administration, oral
Drug-Related side effects and adverse reactions
guidelines for drug use
patient education handout

---
https://ansm.sante.fr/tableau-marr/brolucizumab
2023
false
false
false
France
French
risk management
brolucizumab
intravitreal injections
patients guideline
drug information

---
https://ansm.sante.fr/tableau-marr/avalglucosidase-alfa
2023
false
false
false
France
French
guidelines for drug use
risk management
Infusion-Related Reaction
medication errors
Avalglucosidase Alfa
infusions, intravenous
home infusion therapy
continuity of patient care
enzyme replacement therapy
GAA protein, human
avalglucosidase alfa
monitoring, immunologic
glycogen storage disease type ii

---
https://ansm.sante.fr/tableau-marr/daratumumab
2023
false
false
false
France
French
guideline
patient education handout
risk management
daratumumab
daratumumab
Laboratory test related to immunohematology (procedure)
Laboratory test interference
immunologic tests
hematologic tests

---
https://ansm.sante.fr/tableau-marr/ciltacabtagene-autoleucel
2023
false
false
false
France
French
risk management
guidelines for drug use
patient education handout
Ciltacabtagene Autoleucel
infusions, intravenous
immunotherapy, adoptive
Product containing genetically modified T-cell (product)
Receptors, Chimeric Antigen
Cytokine Release Syndrome
continuity of patient care
Ciltacabtagene Autoleucel
neurotoxicity syndromes
drug compounding
ciltacabtagene autoleucel

---
https://ansm.sante.fr/tableau-marr/rivaroxaban
2023
false
false
false
France
French
Rivaroxaban
risk management
guidelines for drug use
continuity of patient care
administration, oral
medication errors
hemorrhage
Drug-Related side effects and adverse reactions
Rivaroxaban
package leaflet
video recording

---
https://ansm.sante.fr/tableau-marr/apixaban
2023
false
false
false
France
French
guidelines for drug use
risk management
apixaban
administration, oral
apixaban
continuity of patient care
hemorrhage
Drug-Related side effects and adverse reactions
patient education handout

---
https://ansm.sante.fr/tableau-marr/glycopyrronium
2023
false
false
false
France
French
guidelines for drug use
risk management
administration, oral
Glycopyrronium
glycopyrronium
patient education handout
muscarinic antagonists
muscarinic antagonists
Drug-Related side effects and adverse reactions
Drug-Related side effects and adverse reactions
Glycopyrronium
sialorrhea
child
adolescent
chronic disease
nervous system diseases

---
https://ansm.sante.fr/tableau-marr/buprenorphine-1
2023
false
false
false
France
French
patients guideline
buprenorphine
risk management
buprenorphine
administration, sublingual
buprenorphine
narcotics
administration, oral

---
https://ansm.sante.fr/tableau-marr/fosphenytoine-sodique
2023
false
false
false
France
French
risk management
fosphenytoin
fosphenytoin sodium
guidelines for drug use
child
adult
injections, intramuscular
infusions, intravenous
anticonvulsants
fosphenytoin
medication errors
emergency treatment
status epilepticus

---
https://ansm.sante.fr/tableau-marr/eladocagene-exuparvovec
2023
false
false
false
France
French
risk management
guidelines for drug use
Eladocagene Exuparvovec
drug compounding
Stereotactic surgery
stereotaxic techniques
gene therapy
Intraputaminal Route of Administration
aromatic amino acid decarboxylase deficiency
Injection of brain (procedure)
infusions, parenteral
neurosurgical procedures
patient education handout
guideline
eladocagene exuparvovec

---
https://ansm.sante.fr/tableau-marr/luspatercept
2023
false
false
false
France
French
guidelines for drug use
risk management
luspatercept
luspatercept
luspatercept
injections, subcutaneous
hematinics
hematinics
pregnancy
breast feeding
continuity of patient care
patient education handout
checklist
Female of Childbearing Potential
product surveillance, postmarketing
contraception

---
https://ansm.sante.fr/tableau-marr/idecabtagene-vicleucel
2023
false
false
false
France
French
guidelines for drug use
popular works
risk management
idecabtagene vicleucel
idecabtagene vicleucel
Drug-Related side effects and adverse reactions
Drug-Related side effects and adverse reactions
Cytokine Release Syndrome
drug compounding
idecabtagene vicleucel
gene therapy
immunotherapy, adoptive
idecabtagene vicleucel
continuity of patient care
nervous system diseases
infusions, intravenous
Antineoplastic Agents, Immunological
Antineoplastic Agents, Immunological
multiple myeloma
Cytokine Release Syndrome
Cytokine Release Syndrome
signs and symptoms

---
https://ansm.sante.fr/tableau-marr/ranibizumab-1
2023
false
false
false
France
French
risk management
patient education handout
Ranibizumab
Drug-Related side effects and adverse reactions
signs and symptoms
ranibizumab
Product containing precisely ranibizumab 10 milligram/1 milliliter conventional release solution for injection (clinical drug)
intravitreal injections

---
https://ansm.sante.fr/tableau-marr/caplacizumab
2023
false
false
false
France
French
popular works
risk management
continuity of patient care
hemorrhage
caplacizumab
caplacizumab

---
https://ansm.sante.fr/tableau-marr/upadacitinib
2023
false
false
false
France
French
risk management
upadacitinib
patient education handout
guidelines for drug use
upadacitinib
Drug-Related side effects and adverse reactions
administration, oral
upadacitinib
Janus Kinase Inhibitors
Janus Kinase Inhibitors
teratogens
pregnancy
continuity of patient care
herpes zoster
tuberculosis
neoplasms
embolism and thrombosis
Virus Reactivation

---
https://ansm.sante.fr/tableau-marr/tofacitinib
2023
false
false
false
France
French
risk management
tofacitinib
tofacitinib
continuity of patient care
checklist
guidelines for drug use
patient education handout
Janus Kinase Inhibitors
tofacitinib
Drug-Related side effects and adverse reactions
Janus Kinase Inhibitors
pregnancy
teratogens
Virus Reactivation
tuberculosis
neoplasms
embolism and thrombosis
herpes zoster

---
https://ansm.sante.fr/tableau-marr/baricitinib
2023
false
false
false
France
French
risk management
guidelines for drug use
patient education handout
baricitinib
baricitinib
continuity of patient care
Janus Kinase Inhibitors
Drug-Related side effects and adverse reactions
Janus Kinase Inhibitors
baricitinib

---
https://ansm.sante.fr/tableau-marr/adrenaline
2023
false
false
false
France
French
risk management
guidelines for drug use
epinephrine
epinephrine
Self injection
self administration
patient education handout

---
https://ansm.sante.fr/tableau-marr/alglucosidase-alpha
2023
false
false
false
France
French
guidelines for drug use
risk management
alpha-Glucosidases
alpha-Glucosidases
alpha-Glucosidases

---
https://ansm.sante.fr/tableau-marr/ravulizumab
2023
false
false
false
France
French
risk management
ravulizumab
ravulizumab
ravulizumab
infusions, intravenous
guidelines for drug use
patients guideline
continuity of patient care
meningococcal infections
sepsis
neisseria meningitidis
vaccination
antibiotic prophylaxis
meningococcal infections
sepsis
child
infant
hemoglobinuria, paroxysmal
Atypical Hemolytic Uremic Syndrome
myasthenia gravis, generalized

---
https://ansm.sante.fr/tableau-marr/faricimab
2023
false
false
false
France
French
risk management
faricimab
risk
patient education handout
faricimab
intravitreal injections
Drug-Related side effects and adverse reactions
signs and symptoms
wet macular degeneration
diabetic retinopathy
Macular edema due to diabetes mellitus (disorder)
patients guideline
sound

---
https://ansm.sante.fr/tableau-marr/elosulfase-alfa
2023
false
false
false
France
French
guidelines for drug use
risk management
elosulfase alfa
elosulfase alfa
infusions, intravenous
infusion rate
drug dosage calculations

---
https://ansm.sante.fr/tableau-marr/dexamethasone
2023
false
false
false
France
French
patient education handout
risk management
dexamethasone
intravitreal injections

---
https://ansm.sante.fr/tableau-marr/eliglustat
2023
false
false
false
France
French
risk management
eliglustat
guidelines for drug use
drug interactions

---
https://ansm.sante.fr/tableau-marr/etanercept
2023
false
false
false
France
French
patients guideline
drug information
biosimilar pharmaceuticals
risk management

---
https://ansm.sante.fr/tableau-marr/anakinra
2023
false
false
false
France
French
risk management
anakinra
guidelines for drug use
patient education handout

---
https://ansm.sante.fr/tableau-marr/patisiran
2023
false
false
false
France
French
risk management
patisiran
patisiran
guidelines for drug use
patisiran
infusions, intravenous
Drug-Related side effects and adverse reactions
patient education handout
Adverse reaction caused by drug or medicament administered by infusion (disorder)
Infusion Site Reaction
Infusion Site Reaction
signs and symptoms

---
https://ansm.sante.fr/tableau-marr/glofitamab
2023
false
false
false
France
French
guidelines for drug use
risk management
antibodies, bispecific
antibodies, bispecific
glofitamab
glofitamab
patients guideline
Tumor Flare Reaction
signs and symptoms
continuity of patient care
Cytokine Release Syndrome
glofitamab

---
https://ansm.sante.fr/tableau-marr/lisocabtagene-maraleucel
2023
false
false
false
France
French
guidelines for drug use
risk management
Lisocabtagene Maraleucel
Lisocabtagene Maraleucel
Product containing only lisocabtagene maraleucel in parenteral dose form (medicinal product form)
Cytokine Release Syndrome
continuity of patient care
gene therapy
immunotherapy, adoptive
signs and symptoms
nervous system diseases
patients guideline
lisocabtagene maraleucel

---
https://ansm.sante.fr/tableau-marr/eculizumab-1
2023
false
false
false
France
French
risk management
guidelines for drug use
eculizumab
eculizumab
continuity of patient care
Drug-Related side effects and adverse reactions
vaccination
patients guideline
Infections
sepsis
meningococcal infections

---
https://ansm.sante.fr/tableau-marr/naloxone-3
2023
false
false
false
France
French
risk management
video recording
guidelines for drug use
patients guideline
naloxone
naloxone
administration, intranasal

---
https://ansm.sante.fr/tableau-marr/lomitapide
2023
false
false
false
France
French
risk management
lomitapide
lomitapide
patient education handout
guideline
drug interactions
anticholesteremic agents
lomitapide
anticholesteremic agents
administration, oral

---
https://ansm.sante.fr/tableau-marr/teriflunomide
2023
false
false
false
France
French
administration, oral
risk reduction
patients guideline
handbooks
pregnancy
teratogens
teriflunomide
risk management
contraception
Contraindications, Drug
breast feeding
Chemical and Drug Induced Liver Injury
continuity of patient care
multiple sclerosis, relapsing-remitting
leukopenia
hypertension
opportunistic infections
teriflunomide
crotonates
toluidines
crotonates
toluidines

---
https://ansm.sante.fr/tableau-marr/alemtuzumab
2023
false
false
false
France
French
risk management
Alemtuzumab
Alemtuzumab
alemtuzumab
infusions, intravenous
continuity of patient care
multiple sclerosis, relapsing-remitting
guidelines for drug use
patients guideline
patient education as topic
Drug-Related side effects and adverse reactions
drug monitoring
clinical chemistry tests
thyroid diseases
purpura, thrombocytopenic, idiopathic
kidney diseases
anti-glomerular basement membrane disease
Infections
pregnancy
mass screening
Contraindications, Drug
premedication

---
https://ansm.sante.fr/tableau-marr/alitretinoine
2023
false
false
false
France
French
guidelines for drug use
patients guideline
forms
administration, oral
teratogens
pregnancy
contraception
alitretinoin
mental disorders
dyslipidemias
continuity of patient care
pancreatitis
transaminases
Chemical and Drug Induced Liver Injury
drug monitoring
risk management
clinical chemistry tests
patient education handout
tretinoin
tretinoin
Alitretinoin
Alitretinoin

---
https://ansm.sante.fr/tableau-marr/deferasirox
2023
false
false
false
France
French
administration, oral
risk management
medication errors
guidelines for drug use
patient education handout
continuity of patient care
Deferasirox

---
https://ansm.sante.fr/tableau-marr/emicizumab
2023
false
false
false
France
French
emicizumab
risk management
thromboembolism
hemorrhage
thrombotic microangiopathies
blood coagulation tests
risk
hemorrhage
hemophilia A
patients guideline
guidelines for drug use
handbooks
Drug-Related side effects and adverse reactions
injections, subcutaneous
emicizumab
antibodies, bispecific
antibodies, monoclonal, humanized

---
https://ansm.sante.fr/tableau-marr/levonorgestrel-diu
2023
false
false
false
France
French
administration, intravaginal
levonorgestrel
risk management
patient education handout
intrauterine devices, medicated
plastic iud with progestogen
pregnancy, ectopic
risk
guideline
Insertion of intrauterine contraceptive device (procedure)
Contraceptive Effectiveness

---
https://ansm.sante.fr/tableau-marr/lutecium-177lu-oxodotreotide
2023
false
false
false
France
French
lutetium Lu 177 dotatate
risk management
patients guideline
lutetium Lu 177 dotatate
infusions, intravenous
radiotherapy
radiopharmaceuticals
radiopharmaceuticals
neuroendocrine tumors
lutetium (177Lu) oxodotreotide
drug information
organometallic compounds
octreotide
octreotide
organometallic compounds
octreotide

---
https://ansm.sante.fr/tableau-marr/rituximab
2023
false
false
false
France
French
risk management
Rituximab
Rituximab
infusions, intravenous
injections, subcutaneous
rituximab
guidelines for drug use
risk
leukoencephalopathy, progressive multifocal
Infections
Drug-Related side effects and adverse reactions
continuity of patient care
drug monitoring
patient education handout
drug compounding

---
https://ansm.sante.fr/tableau-marr/rituximab-1
2023
false
false
false
France
French
Rituximab
Rituximab
risk management
infusions, intravenous
rituximab
medication errors
guidelines for drug use
patient education handout
risk
leukoencephalopathy, progressive multifocal
Infections
Drug-Related side effects and adverse reactions
continuity of patient care
drug monitoring

---
https://ansm.sante.fr/tableau-marr/rituximab-2
2023
false
false
false
France
French
Rituximab
Rituximab
risk management
Drug-Related side effects and adverse reactions
patient education handout
guidelines for drug use
infusions, intravenous
rituximab
leukoencephalopathy, progressive multifocal
Infections
medication errors
continuity of patient care

---
https://ansm.sante.fr/tableau-marr/valproate-et-derives
2023
false
false
false
France
French
risk management
valproate
pregnancy
teratogens
valproate sodium
-
Divalproex Sodium
dipropylacetamide
pregnancy tests
contraception
guideline
patient education handout
forms
developmental disabilities
Contraindications, Drug
valproic acid
valproic acid

---
https://ansm.sante.fr/tableau-marr/darbepoetin-alfa
2023
false
false
false
France
French
risk management
Darbepoetin alfa
darbepoetin alfa
hematinics
self administration
Self-administration error
patients guideline
checklist
injections
guidelines for drug use

---
https://ansm.sante.fr/tableau-marr/eculizumab
2023
false
false
false
France
French
risk management
guidelines for drug use
eculizumab
eculizumab
continuity of patient care
drug monitoring
patient safety
sepsis
meningococcal infections
risk
vaccination
antibiotic prophylaxis
adult
child
infant
patients guideline
patient education handout

---
https://ansm.sante.fr/tableau-marr/baclofene
2023
false
false
false
France
French
baclofen
baclofen
risk management
guidelines for drug use
patients guideline
patient education handout
continuity of patient care
drug monitoring
alcoholism

---
https://ansm.sante.fr/tableau-marr/propranolol
2023
false
false
false
France
French
risk management
propranolol
propranolol hydrochloride
administration, oral
guidelines for drug use
patients guideline
child
Drug-Related side effects and adverse reactions
bronchial spasm
hypoglycemia
convulsive seizures
adrenergic beta-antagonists
hemangioma, capillary
propranolol

---
https://ansm.sante.fr/tableau-marr/atidarsagene-autotemcel
2023
false
false
false
France
French
guidelines for drug use
pharmacovigilance note
Atidarsagene Autotemcel
risk management
infusions, intravenous
gene therapy
atidarsagene autotemcel
biological products

---
https://ansm.sante.fr/tableau-marr/onasemnogene-abeparvovec
2023
false
false
false
France
French
guidelines for drug use
risk management
Zolgensma
onasemnogene abeparvovec
infusions, intravenous
patients guideline
child
spinal muscular atrophies of childhood
onasemnogene abeparvovec-xioi
biological products
recombinant fusion proteins

---
https://ansm.sante.fr/tableau-marr/agalsidase-beta
2023
false
false
false
France
French
risk management
agalsidase beta
guidelines for drug use
patients guideline
infusions, intravenous
enzyme replacement therapy
fabry disease
continuity of patient care
home health nursing

---
https://ansm.sante.fr/tableau-marr/methoxyflurane
2023
false
false
false
France
French
risk management
methoxyflurane
administration, inhalation
guidelines for drug use
methoxyflurane
methoxyflurane
Drug-Related side effects and adverse reactions
emergency treatment
pain
wounds and injuries
Post-traumatic pain

---
https://ansm.sante.fr/tableau-marr/imiglucerase
2023
false
false
false
France
French
guidelines for drug use
risk management
imiglucerase
imiglucerase
infusions, intravenous
enzyme replacement therapy
home nursing
gaucher disease
home infusion therapy
home infusion therapy

---
https://ansm.sante.fr/tableau-marr/insuline-degludec-liraglutide
2022
false
false
false
France
French
guidelines for drug use
risk management

---
https://www.yearbook-ers.jle.com/e-docs/perceptions_et_attentes_sur_la_gestion_des_risques_incertains_des_biotechnologies_emergentes_aux_pays_bas_322297/yb_breve.phtml
2022
false
false
false
France
journal article
biotechnology
perception
risk management
attention

---
https://ansm.sante.fr/tableau-marr/fentanyl-7
2022
false
false
false
France
French
fentanyl
risk management
Fentanyl Citrate
guidelines for drug use
patients guideline
narcotics
analgesics, opioid
administration, intranasal
fentanyl
nasal sprays

---
https://ansm.sante.fr/tableau-marr/cemiplimab
2022
false
false
false
France
French
risk management
patients guideline
cemiplimab
Antineoplastic Agents, Immunological
infusions, intravenous
cemiplimab
drug monitoring

---
https://ansm.sante.fr/tableau-marr/blinatumomab
2022
false
false
false
France
French
risk management
medication errors
blinatumomab
continuity of patient care
guidelines for drug use
guideline
patient education handout
nervous system diseases
Neurotoxicity (disorder)
antineoplastic agents
blinatumomab
infusions, intravenous

---
https://ansm.sante.fr/tableau-marr/hemine-humaine
2022
false
false
false
France
French
risk management
hemin
guidelines for drug use
continuity of patient care
infusions, intravenous
Drug-Related side effects and adverse reactions
Injection Site Reaction
hemin

---
https://ansm.sante.fr/tableau-marr/misoprostol
2022
false
false
false
France
French
risk management
misoprostol
administration, oral
abortion, Drug-Induced
guidelines for drug use
patient education handout
teratogens
continuity of patient care
office visits
abortifacient agents, nonsteroidal
misoprostol

---
https://ansm.sante.fr/tableau-marr/satralizumab
2022
false
false
false
France
French
risk management
satralizumab
drug information
patient education handout
Interleukin Inhibitors
satralizumab
injections, subcutaneous
Infections

---
https://ansm.sante.fr/actualites/virus-de-la-variole-du-singe-recommandations-pour-securiser-les-dons-de-selles-dans-le-cadre-de-la-transplantation-de-microbiote-fecal-tmf
2022
false
false
false
France
French
guideline
Mpox (monkeypox)
monkeypox virus
Fecal Microbiota Transplantation
risk management
patient safety

---
https://ansm.sante.fr/tableau-marr/tocilizumab
2022
false
false
false
France
French
risk management
guidelines for drug use
patients guideline
continuity of patient care
patient education handout
tocilizumab
tocilizumab
tocilizumab
tocilizumab
injections, subcutaneous
infusions, intravenous
receptors, interleukin-6
interleukin 6 receptor inhibitor
self administration

---
https://ansm.sante.fr/dossiers-thematiques/fluoroquinolones
2022
false
false
false
France
French
fluoroquinolones
fluoroquinolones
guidelines for drug use
risk management
anti-bacterial agents
anti-bacterial agents
fluoroquinolones
Drug-Related side effects and adverse reactions

---
https://ansm.sante.fr/tableau-marr/lauromacrogol-400
2022
false
false
false
France
French
risk management
guidelines for drug use

---
https://ansm.sante.fr/tableau-marr/sufentanyl
2022
false
false
false
France
French
guidelines for drug use
sufentanil
drug prescriptions
administration, sublingual
risk management
continuity of patient care
adult
acute pain
analgesics, opioid
sufentanil
analgesics, opioid

---
https://ansm.sante.fr/tableau-marr/olipudase-alfa
2022
false
false
false
France
French
guidelines for drug use
popular works
risk management
olipudase alfa
olipudase alfa
Drug-Related side effects and adverse reactions
infusions, intravenous
home infusion therapy
Infusion-Related Reaction
drug hypersensitivity
anaphylaxis
olipudase alfa

---
https://ansm.sante.fr/tableau-marr/proteines-darachide-sous-forme-de-poudre-de-graine-darachis-hypogaea-l-arachide-allegee-en-graisses
2022
false
false
false
France
French
guidelines for drug use
risk management
patients guideline

---
https://dumas.ccsd.cnrs.fr/dumas-03977393
2022
France
dissertations, academic
cues
pharmacovigilance
clinical trial
clinical trials as topic
risk management
detective

---
https://ansm.sante.fr/tableau-marr/avelumab
2022
false
false
false
France
French
immune system diseases
avelumab
avelumab
Drug-Related side effects and adverse reactions
Infusion related reaction
signs and symptoms
patient education handout
infusions, intravenous
avelumab
risk management
immune system diseases
antineoplastic agents
antineoplastic agents
Drug-Related side effects and adverse reactions
immune system diseases
guidelines for drug use
patients guideline
antibodies, monoclonal
antibodies, monoclonal

---
https://ansm.sante.fr/tableau-marr/hydroxycarbamide
2022
false
false
false
France
French
teratogens
hydroxyurea
hydroxyurea
continuity of patient care
guidelines for drug use
risk management
anemia, sickle cell
pain
adult
child
adolescent
fertility
pregnancy
contraception
blood cell count
hematologic diseases
patients guideline
package leaflet

---
https://ansm.sante.fr/tableau-marr/insuline-degludec
2022
false
false
false
France
French
risk management
insulin degludec
medication errors
guidelines for drug use
injections, subcutaneous
insulin degludec
patient education handout
hypoglycemic agents
insulin, long-acting

---
https://www.inspq.qc.ca/publications/2910-cas-contacts-chsld-covid19
2022
false
false
false
Canada
quebec
residential facilities
aged
homes for the aged
infection control
early diagnosis
signs and symptoms
coronavirus infections
risk management
guideline
case management
pneumonia, viral
coronavirus infections
pneumonia, viral
pneumonia, viral
COVID-19
COVID-19

---
https://ansm.sante.fr/tableau-marr/natalizumab
2022
false
false
false
France
French
guidelines for drug use
patient education handout
Natalizumab
injections, subcutaneous
infusions, intravenous
risk management
Natalizumab
leukoencephalopathy, progressive multifocal
multiple sclerosis
continuity of patient care
risk assessment
natalizumab

---
https://ansm.sante.fr/tableau-marr/naloxone-2
2022
false
false
false
France
French
guidelines for drug use
risk management
naloxone
naloxone
injections, intramuscular
patient education handout
patients guideline
naloxone
emergency treatment
Opiate Overdose
narcotic antagonists
antidotes

---
https://ansm.sante.fr/tableau-marr/acide-zoledronique
2022
false
false
false
France
French
risk management
patients guideline
guidelines for drug use
Zoledronic Acid
Drug-Related side effects and adverse reactions
bone density conservation agents
Bisphosphonate-Associated osteonecrosis of the jaw
risk
zoledronic acid

---
https://ansm.sante.fr/tableau-marr/adrenaline-3
2022
false
false
false
France
French
risk management
epinephrine
guidelines for drug use
self administration
injections, intramuscular
epinephrine
anaphylaxis
patients guideline
drug storage

---
https://ansm.sante.fr/tableau-marr/buprenorphine-naloxone
2022
false
false
false
France
French
guidelines for drug use
Buprenorphine, Naloxone Drug Combination
Buprenorphine, Naloxone Drug Combination
risk management
administration, sublingual
buprenorphine, combinations
patients guideline
opioid-related disorders
opiate substitution treatment
continuity of patient care
pregnancy
breast feeding
hepatic insufficiency
drug interactions

---
https://ansm.sante.fr/tableau-marr/ozanimod
2022
false
false
false
France
French
risk management
ozanimod
ozanimod
guidelines for drug use
Product containing precisely ozanimod (as ozanimod hydrochloride) 230 microgram/1 each conventional release oral capsule (clinical drug)
Product containing precisely ozanimod (as ozanimod hydrochloride) 460 microgram/1 each conventional release oral capsule (clinical drug)
Product containing precisely ozanimod (as ozanimod hydrochloride) 920 microgram/1 each conventional release oral capsule (clinical drug)
ozanimod
administration, oral
continuity of patient care
patients guideline
pregnancy
ozanimod

---
https://ansm.sante.fr/tableau-marr/metreleptine
2022
false
false
false
France
French
risk management
guidelines for drug use
metreleptin
metreleptin
metreleptin
injections, subcutaneous
drug compounding
withdrawing treatment
Leptin Deficiency
lipodystrophy
continuity of patient care
pregnancy

---
https://ansm.sante.fr/tableau-marr/velaglucerase-alfa
2022
false
false
false
France
French
risk management
velaglucerase alfa, human
Velaglucerase Alfa
Velaglucerase Alfa
guidelines for drug use
infusions, intravenous
drug hypersensitivity
infusions, intravenous
continuity of patient care
velaglucerase alfa
patients guideline
patient safety
enzyme replacement therapy
gaucher disease
Infusion-Related Reaction
home nursing

---
https://www.irsst.qc.ca/publications-et-outils/publication/i/101147/n/systeme-gestion-risques-fatigue-policiers
2022
false
false
false
Canada
video recording
fatigue
police
risk management

---
https://www.hcsp.fr/explore.cgi/avisrapportsdomaine?clefr=1174
2022
France
public health guidelines
risk management
drinking
pesticide, nos
homo sapiens
water consumption
judgment
emigration and immigration
relative risk
humans
pesticides
hazardous substances
risk

---
https://ansm.sante.fr/tableau-marr/acitretine
2021
false
false
false
France
French
guidelines for drug use
patients guideline
risk management
teratogens
continuity of patient care
acitretin
acitretin
pregnancy
contraception
administration, oral
acitretin
mental disorders
drug monitoring
Chemical and Drug Induced Liver Injury
pancreatitis
psoriasis

---
https://www.hcsp.fr/explore.cgi/avisrapportsdomaine?clefr=1137
2021
France
public health guidelines
Wastes
waste management
risk management
medical waste
equipment and supplies
equipment
Electronics
trash
managed care programs
electrons
electronics
nursing
electron

---
https://ansm.sante.fr/tableau-marr/isotretinoine
2021
false
false
false
France
French
administration, oral
isotretinoin
risk management
acne vulgaris
isotretinoin
teratogens
pregnancy
contraception
mental disorders
dyslipidemias
Chemical and Drug Induced Liver Injury
patient education handout
forms
pancreatitis
guidelines for drug use
continuity of patient care
Drug-Related side effects and adverse reactions

---
https://ansm.sante.fr/tableau-marr/etonogestrel
2021
false
false
false
France
French
risk management
guidelines for drug use
patients guideline
patient education handout
etonogestrel
drug implants
Insertion of etonogestrel radiopaque contraceptive implant (procedure)
Removal of etonogestrel radiopaque contraceptive implant (procedure)
Insertion of subcutaneous contraceptive in arm (procedure)
etonogestrel
contraceptive agents, female
progestins

---
https://ansm.sante.fr/tableau-marr/colistimethate-de-sodium
2021
false
false
false
France
French
risk management
administration, inhalation
guidelines for drug use
colistimethate sodium
colistin
patient education handout
colistimethate sodium

---
https://ansm.sante.fr/dossiers-thematiques/covid-19-vaccins/covid-19-dispositif-de-surveillance-renforcee-des-vaccins
2021
false
false
false
France
French
risk management
adverse drug reaction reporting systems
drug information
pharmacovigilance
Drug-Related side effects and adverse reactions
france
vaccination
pneumonia, viral
coronavirus infections
pandemics
viral vaccines
coronavirus infections
COVID-19
COVID-19 Vaccines

---
https://www.inspq.qc.ca/publications/3106-exposition-aerosols-travailleurs-sante-milieux-soins
2021
Canada
pneumonia, viral
coronavirus infections
public health guidelines
aerosols
risk management
health care
hazardous substances
delivery of health care
effects of exposure to external cause, nos
health fairs
uncontrolled
aerosol sprayer
Aerosols
health personnel
aerosol, nos
Exhibition
occupational exposure
COVID-19

---
https://publications.msss.gouv.qc.ca/msss/document-002911/
2021
Canada
pneumonia, viral
coronavirus infections
public health guidelines
Aerosols
guideline
Exhibition
aerosols
effects of exposure to external cause, nos
aerosol sprayer
risk management
aerosol, nos
guideline
pandemics
COVID-19

---
https://drees.solidarites-sante.gouv.fr/publications/etudes-et-resultats/risques-encourus-gestion-de-lepidemie-suivi-des-patients-opinions
2021
false
false
false
France
journal article
containment of biohazards
epidemics
risk management
Physicians
general practitioners
Intertrochanteric fracture
continuity of patient care
disease outbreaks
has patient
epidemics

---
https://www.inesss.qc.ca/publications/repertoire-des-publications/publication/evaluation-et-gestion-du-risque-de-complications-neurologiques-graves-a-la-suite-dun-traumatisme-craniocerebral-leger.html
2021
false
false
false
Canada
guideline
brain concussion
risk management

---
https://www.inesss.qc.ca/accueil/nouveaute/mise-a-jour-des-algorithmes-decisionnels-pour-la-gestion-du-risque-de-complications-neurologiques-graves-a-la-suite-dun-traumatisme-craniocerebral-leger-tccl.html
2021
Canada
algorithms
risk management
Trauma
brain concussion
complication, nos
algorithms
injury, nos
neurology
Neurology

---
https://publications.msss.gouv.qc.ca/msss/document-003067/
2021
Canada
COVID-19
algorithms
coronavirus
risk assessment
coronavirus, nos
residence characteristics
operations research
risk management
community
case management
risk management
pneumonia, viral
coronavirus infections
pandemics

---
https://hal-lara.archives-ouvertes.fr/hal-03267088
2021
false
false
false
France
health policy
technical report
risk management
environmental exposure
Dietary Exposure
Natural Disasters
economic evaluation
environmental health
hazardous substances
risk

---
https://ansm.sante.fr/informations-de-securite/nouvelles-conditions-de-prescription-et-de-delivrance-des-specialites-a-base-dacetate-de-nomegestrol-lutenyl-et-generiques-et-dacetate-de-chlomadinone-luteran-et-generiques-liees-au-risque-de-meningiome
2021
false
false
false
France
French
meningioma
guidelines for drug use
nomegestrol acetate
nomegestrol acetate
chlormadinone acetate
chlormadinone acetate
risk management
chlormadinone acetate
chlormadinone acetate
megestrol
norpregnadienes
megestrol
norpregnadienes

---
https://sides.uness.fr/corpus/Anesth%C3%A9sie-R%C3%A9animation:La_s%C3%A9curit%C3%A9_du_patient,_la_gestion_des_risques,_les_%C3%A9v%C3%A8nements_ind%C3%A9sirables_associ%C3%A9s_aux_soins
2021
true
false
false
true
France
French
educational course
resuscitation
anesthesiology
patient safety
risk management
therapeutics
quality of health care
disinfection
decontamination
sterilization
asepsis
antisepsis
cross infection
urinary tract infections
Healthcare-Associated Pneumonia
surgical wound infection
vascular access devices

---
https://ansm.sante.fr/tableau-marr/methadone
2021
false
false
false
France
French
risk management
methadone
administration, oral
patient education handout
accidents, home
patients guideline
drug information
child
Accidental ingestion of drug
Accidental poisoning caused by methadone (disorder)

---
https://ansm.sante.fr/tableau-marr/tenofovir-disoproxil-associe-a-ellvitegravir-cobicistat-et-emtricitabine
2021
false
false
false
France
French
guidelines for drug use
risk management
stribild
administration, oral
Elvitegravir, Cobicistat, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination
Elvitegravir, Cobicistat, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination
kidney diseases
bone diseases
continuity of patient care
drug monitoring
adolescent
anti-hiv agents
emtricitabine, tenofovir disoproxil, elvitegravir and cobicistat

---
https://ansm.sante.fr/tableau-marr/levodopa-carbidopa
2021
false
false
false
France
French
risk management
carbidopa
levodopa
drug combinations
carbidopa, levodopa drug combination
Intestinal Route of Administration
patient care
nursing care
patient care planning
guidelines for drug use
patient education handout

---
http://www.theses.fr/2020GRALS033
2020
France
dissertations, academic
hazardous substances
malingering
competence
Techniques
health
Techniques
black fly, nos
risk management
professional competence
Techniques
Simulation
technical expertise
Techniques
health

---
http://www.fcvd.fr/wp-content/uploads/2020/04/CNP.CVD-COVID-Guide-de-bonnes-pratiques.pdf
2020
France
pneumonia, viral
coronavirus infections
guideline
communication
Solutions
Safety
solution, nos
Communication
solutions
patient safety
has patient
risk management
safety management
Communication
solutions
risk management
pandemics
COVID-19

---
https://www.ssmg.be/wp-content/uploads/RMG/367/RMG367_06-15.pdf
2020
Belgium
journal article
Lipids
lipid, nos
cardiovascular risk
Lipids
lipids
risk management
Lipids

---
https://ansm.sante.fr/tableau-marr/midazolam
2019
false
false
false
France
French
risk management
midazolam
continuity of patient care
drug monitoring
seizures
forms
patient education handout
midazolam
guidelines for drug use

---
https://ansm.sante.fr/tableau-marr/pembrolizumab
2019
false
false
false
France
French
risk management
pembrolizumab
Infusion related reaction
immune system diseases
Drug-Related side effects and adverse reactions
patient education handout
pregnancy
continuity of patient care
drug monitoring
guideline
Antineoplastic Agents, Immunological
pembrolizumab
antibodies, monoclonal
antibodies, monoclonal, humanized

---
https://ansm.sante.fr/tableau-marr/rivastigmine
2019
false
false
false
France
French
guidelines for drug use
patients guideline
risk management
Rivastigmine
rivastigmine
transdermal patch
administration, cutaneous
drug overdose
prescription drug misuse
medication errors

---
https://www.has-sante.fr/portail/jcms/c_2905932/fr/simulation-en-sante-et-gestion-des-risques
2019
France
technical report
health
malingering
Simulation
hazardous substances
black fly, nos
risk management
health

---
https://www.has-sante.fr/jcms/p_3330409
2019
false
false
false
France
guideline
Methodology
malingering
Methodology
methods
tool, nos
hazardous substances
black fly, nos
professional practice
Methodology
health
Simulation
risk-taking
Handbook
Practice
risk management

---
http://www.sudoc.fr/236889540
2019
France
dissertations, academic
hopefulness
Optimism
critical pathways
screening
risk assessment
patient participation
patient satisfaction
pregnancy, high-risk
has patient
first trimester pregnancy
pregnancy trimester, first
risk management
hope
mass screening
risk management

---
http://www.cpias-ile-de-france.fr/docprocom/doc/Prise-en-charge-MCJ-2019_V2.pdf
2019
false
false
false
France
prion diseases
risk management
infectious disease transmission, Patient-to-Professional
specimen handling
equipment and supplies
death
guideline
creutzfeldt-jakob syndrome

---
https://youtu.be/YF80aoP-mJ8
https://sesstim.univ-amu.fr/video-box/seminaire-interne-du-sesstim-marion-di-ciaccio-0
2019
France
audiovisual aids
Essay
internal medicine specialist
psychosocial risk
HIV
men
sexual intercourse, nos
risk management
unsafe sex
human immunodeficiency virus, nos

---
https://www.inesss.qc.ca/publications/repertoire-des-publications/publication/la-gestion-du-risque-suicidaire-et-des-comportements-dautomutilation-chez-les-jeunes-heberges-en-centre-de-readaptation-pour-jeunes-en-difficulte-dadaptation.html
2019
false
false
false
Canada
guideline
risk behavior
self mutilation
risk management
risk-taking
suicidal ideation
self-inflicted injury, nos
Self injury
suicidal behavior

---
http://www.fcvd.fr/journee-nationale-2018-synthese-et-recommandation/
2019
false
false
false
France
guideline
operative procedure, nos
Surgery
digestants
digestion
Program
digestant, nos
solution, nos
patient safety
Safety
digestive system surgical procedures
risk management
digestive tract function, nos
Solutions
has patient
safety management
solutions
digestive surgery
reoperation
gastrointestinal agents
digestion
risk management
solutions

---
http://sfar.org/wp-content/uploads/2018/03/2_Gestion-des-agents-antiplaquettaires-pour-une-procedure-invasive-programmee.pdf
https://doi.org/10.1016/j.anrea.2018.01.002
2018
false
false
false
France
French
platelet aggregation inhibitors
hemorrhage
postoperative complications
platelet aggregation inhibitors
embolism and thrombosis
aspirin
administration, oral
Prasugrel Hydrochloride
risk management
risk assessment
continuity of patient care
patient safety
purinergic P2Y receptor antagonists
purinergic P2Y receptor antagonists
platelet aggregation inhibitors excl. heparin
surgical procedures, operative
blood loss, surgical
perioperative period
ticlopidine
ticlopidine
adenosine
adenosine
Clopidogrel
Ticagrelor

---
http://www.acadpharm.org/dos_public/Recommandations_HygiEne_HospitaliEre_VF_2018.03.08.pdf
2018
false
false
false
France
French
infection control practitioners
professional role
guideline
risk management
infections, hospital
cross infection

---
https://www.ansm.sante.fr/actualites/actualisation-des-mesures-de-reduction-du-risque-lie-a-lexposition-au-mycophenolate-au-cours-de-la-grossesse
2018
false
false
false
France
French
pharmacovigilance note
teratogens
drugs, generic
mycophenolic acid
Mycophenolate Sodium
legislation, drug
drug prescriptions
patient education as topic
guidelines for drug use
pregnancy
risk management
risk
contraception
Mycophenolate Sodium
male contraception
female contraception
risk reduction
Drug-Related side effects and adverse reactions
Contraindications, Procedure
mycophenolic acid
mycophenolic acid
mycophenolic acid
risk reduction behavior
Contraindications, Drug

---
nformation destinée aux chirurgiens cardio-thoraciques, chirurgiens digestifs, cardiologues, pneumologues, néphrologues, gastroentérologues, spécialistes de médecine interne, rhumatologues, urologues, anesthésistes-réanimateurs, dermatologues, neurologues, gynécologues, médecins généralistes, pharmaciens hospitaliers et d’officine.
https://ansm.sante.fr/informations-de-securite/mycophenolate-mofetil-cellcept-r-et-ses-generiques-et-mycophenolate-sodique-myfortic-r-modification-des-recommandations-en-matiere-de-contraception
2018
false
false
false
France
French
pharmacovigilance note
teratogens
drugs, generic
mycophenolic acid
Mycophenolate Sodium
legislation, drug
drug prescriptions
patient education as topic
guidelines for drug use
pregnancy
risk management
patients guideline
risk
contraception
forms
Mycophenolate Sodium
male contraception
female contraception
risk reduction
Drug-Related side effects and adverse reactions
Contraindications, Procedure
mycophenolic acid
mycophenolic acid
mycophenolic acid
risk reduction behavior
Contraindications, Drug

---
https://www.ansm.sante.fr/actualites/reduction-du-risque-lie-a-lexposition-au-mycophenolate-au-cours-de-la-grossesse-mise-a-disposition-des-guides-et-du-formulaire-daccord-de-soins-actualises
2018
false
false
false
France
French
pharmacovigilance note
teratogens
drugs, generic
mycophenolic acid
Mycophenolate Sodium
legislation, drug
drug prescriptions
patient education as topic
guidelines for drug use
pregnancy
risk management
risk
contraception
Mycophenolate Sodium
male contraception
female contraception
risk reduction
Drug-Related side effects and adverse reactions
Exposure during pregnancy
patients guideline
forms
Contraindications, Procedure
mycophenolic acid
mycophenolic acid
mycophenolic acid
risk reduction behavior
Contraindications, Drug

---
https://www.has-sante.fr/portail/jcms/c_2882414/fr/comment-gerer-les-risques-associes-a-l-utilisation-du-bistouri-electrique
2018
false
false
false
France
French
surgical instruments
risk management
burns, electric
burns, electric
intraoperative complications
fires
disinfection
operating rooms
anti-infective agents, local
digestive system surgical procedures
electrosurgery
guideline

---
https://www.jogc.com/article/S1701-2163(18)30070-7/abstract
2018
Canada
guideline
french abstract
fetal monitoring
fetus, nos
quality improvement
risk management
total quality management
fetus
standards
fetus
reference standards

---
https://ansm.sante.fr/tableau-marr/agomelatine
2018
false
false
false
France
French
depressive disorder, major
patients guideline
guidelines for drug use
continuity of patient care
drug monitoring
drug interactions
cytochrome p-450 cyp1a2
agomelatine
agomelatine
antidepressive agents
antidepressive agents
agomelatine
liver function tests
risk management
Chemical and Drug Induced Liver Injury
risk factors
transaminases
administration, oral
agomelatine
agomelatine
acetamides
acetamides

---
https://ansm.sante.fr/tableau-marr/atezolizumab
2018
false
false
false
France
French
atezolizumab
atezolizumab
atezolizumab
Drug-Related side effects and adverse reactions
risk management
scientific and technical information
patient education handout
Drug-Related side effects and adverse reactions
signs and symptoms
antineoplastic agents
antineoplastic agents
immune system diseases
immune system diseases
antibodies, monoclonal
antibodies, monoclonal

---
https://ansm.sante.fr/tableau-marr/clozapine
2018
false
false
false
France
French
clozapine
risk management
patient education handout
blood cell count
forms
agranulocytosis
continuity of patient care
drug monitoring

---
https://ansm.sante.fr/tableau-marr/emtricitabine-tenofovir-disoproxil
2018
false
false
false
France
French
Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination
risk management
Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination
hiv infections
patient education handout
continuity of patient care
scientific and technical information
Pre-Exposure Prophylaxis
Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination
guidelines for drug use
adult
adolescent
Seroconversion
drug resistance, viral
patient compliance
kidney diseases
creatinine
risk reduction behavior
mass screening
hiv infections
pregnancy
tenofovir disoproxil and emtricitabine
anti-hiv agents
anti-hiv agents

---
https://ansm.sante.fr/tableau-marr/ipilimumab
2018
false
false
false
France
French
Ipilimumab
risk management
patient education handout
Ipilimumab
adult
adolescent
melanoma
immune system diseases
Drug-Related side effects and adverse reactions
ipilimumab

---
https://ansm.sante.fr/tableau-marr/mefloquine
2018
false
false
false
France
French
mefloquine
patient education handout
malaria
mental disorders
nervous system diseases
risk management
mefloquine
Contraindications, Drug
guidelines for drug use

---
https://ansm.sante.fr/tableau-marr/nivolumab
2018
false
false
false
France
French
risk management
immune system diseases
nivolumab
Drug-Related side effects and adverse reactions
guidelines for drug use
antineoplastic agents
immune system diseases
Drug-Related side effects and adverse reactions
summary of product characteristics
patient education handout
Drug-Related side effects and adverse reactions
antibodies, monoclonal
Nivolumab

---
https://ansm.sante.fr/tableau-marr/sonidegib
2018
false
false
false
France
French
risk management
sonidegib
sonidegib
teratogens
pregnancy
abnormalities, drug-induced
contraception
pregnancy tests
antineoplastic agents
fetal death
patient education handout
scientific and technical information
sonidegib
biphenyl compounds
pyridines

---
https://ansm.sante.fr/tableau-marr/vandetanib
2018
false
false
false
France
French
risk management
vandetanib
vandetanib
Cardiotoxicity
adult
child
posterior leukoencephalopathy syndrome
death, sudden
long qt syndrome
torsades de pointes
continuity of patient care
drug monitoring
drug interactions
medication errors
vandetanib
handbooks
popular works
piperidines
quinazolines
piperidines
quinazolines

---
https://ansm.sante.fr/tableau-marr/vismodegib
2018
false
false
false
France
French
patient education handout
risk management
vismodegib
pregnancy
handbooks
contraception
teratogens
pregnancy tests
vismodegib
forms
abnormalities, drug-induced
fertility
fetal death
embryo death
HhAntag691
embryo loss
anilides
pyridines

---
https://dumas.ccsd.cnrs.fr/dumas-02005596/document
2018
France
dissertations, academic
general practitioners
Physicians
Acrogeria
kidney, nos
anti-inflammatory agents, non-steroidal
risk management
iatrogenic disease
prescription, nos
persons
persons

---
https://hal.archives-ouvertes.fr/hal-01902110
2018
France
technical report
Miscellaneous
Miscellaneous
Miscellaneous
Miscellaneous
Miscellaneous
Miscellaneous
Miscellaneous
Miscellaneous
Miscellaneous
Miscellaneous
Miscellaneous
Miscellaneous
Miscellaneous
Miscellaneous
Wastewaters
Miscellaneous
Miscellaneous
Miscellaneous
Miscellaneous
Miscellaneous
Miscellaneous
Miscellaneous
Miscellaneous
Miscellaneous
Miscellaneous
Miscellaneous
Miscellaneous
Miscellaneous
Miscellaneous
Miscellaneous
Miscellaneous
Miscellaneous
Miscellaneous
Miscellaneous
Miscellaneous
Miscellaneous
Miscellaneous
Miscellaneous
Miscellaneous
Miscellaneous
Miscellaneous
Miscellaneous
Miscellaneous
Miscellaneous
Miscellaneous
Miscellaneous
Miscellaneous
Miscellaneous
Miscellaneous
Miscellaneous
Other topics in atmospheric geophysics
Miscellaneous
Miscellaneous
Miscellaneous
sewage
Miscellaneous
Other topics in heat transfer, thermal and thermodynamic processes
Miscellaneous
Miscellaneous
wastewater
Miscellaneous
Miscellaneous
Miscellaneous
Other topics of general interest
Miscellaneous
Miscellaneous
Other topics in solid mechanics
Miscellaneous
Miscellaneous
Wastewater
Miscellaneous
Miscellaneous
Miscellaneous
Miscellaneous
Miscellaneous
Miscellaneous
Miscellaneous
Miscellaneous
Miscellaneous
life
Miscellaneous
Miscellaneous
Miscellaneous
Miscellaneous
Miscellaneous
Miscellaneous
Miscellaneous
Miscellaneous
Miscellaneous
Miscellaneous
Miscellaneous
Miscellaneous
Other topics in lattice dynamics
Miscellaneous
Miscellaneous
Other topics in nuclear reactions: general
Other topics in nanoscale materials and structures
Miscellaneous
Miscellaneous
Miscellaneous
Miscellaneous
Miscellaneous
Miscellaneous
Miscellaneous
Other topics in statistical physics, thermodynamics, and nonlinear dynamical systems
Miscellaneous
Miscellaneous
Miscellaneous
Miscellaneous
Miscellaneous
Miscellaneous
Miscellaneous
Miscellaneous
Miscellaneous
Miscellaneous
Miscellaneous
Miscellaneous
Miscellaneous
Miscellaneous
Miscellaneous
Miscellaneous
Miscellaneous
Miscellaneous
Miscellaneous
Miscellaneous
Miscellaneous
Other topics
Miscellaneous
Miscellaneous
Miscellaneous
Miscellaneous
Miscellaneous
Miscellaneous
Miscellaneous
Miscellaneous
Miscellaneous
Other topics of general interest
Miscellaneous
Miscellaneous
Miscellaneous
Others applications
Miscellaneous
Miscellaneous
Miscellaneous
Miscellaneous
Miscellaneous
Miscellaneous
Miscellaneous
Miscellaneous
Miscellaneous
Miscellaneous
Miscellaneous
Miscellaneous
Miscellaneous
Miscellaneous
Other topics in optics
Miscellaneous
virus, nos
Miscellaneous
Miscellaneous
Miscellaneous
Miscellaneous
Miscellaneous
Miscellaneous
Miscellaneous
Miscellaneous
Miscellaneous
Miscellaneous
Miscellaneous
Miscellaneous
Miscellaneous
Miscellaneous
risk management
Wastewater

---
https://www.has-sante.fr/jcms/c_2854104
2018
false
false
false
France
guideline
equipment and supplies
risk management
equipment
Practice
risk-taking
professional practice
tool, nos

---
http://www.hcsp.fr/explore.cgi/avisrapportsdomaine?clefr=592
2017
false
false
false
France
French
guideline
public health guidelines
safety management
domicile
risk management
residence characteristics
risk management

---
https://hal.archives-ouvertes.fr/tel-01791618
2017
false
false
false
France
French
dissertations, academic
diffusion
drug resistance, bacterial
bacterium, nos
diffusion
antibiotic, nos
risk management
spreading
politics
resistant
diffuse rigidity
Antibiotics
academic medical centers
central
bacteria
antibiotics

---
https://www.jle.com/fr/revues/jpc/e-docs/anticoagulants_chez_les_patients_fragiles_sept_situations_a_risque_310985/article.phtml
10.1684/jpc.2017.0369
2017
false
false
false
France
French
journal article
anticoagulants
anticoagulants
risk management
pregnancy
breast feeding
neoplasms
venous thromboembolism
venous thromboembolism
risk factors
renal insufficiency, chronic
underweight
malnutrition
polypharmacy
cognition disorders
accidental falls
hemorrhage
continuity of patient care
medication adherence
frail elderly
adult
administration, oral
aged
Direct acting anticoagulant (substance)
antivitamins K
heparin, low-molecular-weight
Factor Xa Inhibitors
practice guidelines as topic
injections
Anticoagulant adverse reaction (disorder)
thinness
indenes
4-hydroxycoumarins
vitamin K
vitamin K

---
https://www.anses.fr/fr/system/files/REACH2017SA0072.pdf
2017
false
false
false
France
French
scientific and technical information
occupational
relative
formaldehyde
inlets
risk management
due to
generations
formaldehyde
bays
family characteristics

---
http://www.fcvd.fr/wp-content/uploads/2017/10/Gestion-des-risques-Amb-et-RRAC.pdf
2016
France
guideline
risk management
operative procedure, nos
hospital admission, nos
hospitalization
ambulatory surgical procedures
Surgery

---
http://www.has-sante.fr/portail/jcms/c_547976/fr/suivi-et-orientation-des-femmes-enceintes-en-fonction-des-situations-a-risque-identifiees
http://www.has-sante.fr/portail/jcms/c_605115/fr/suivi-des-femmes-enceintes-recommandations
http://www.has-sante.fr/portail/jcms/c_605125/fr/suivi-des-femmes-enceintes-argumentaire
2016
true
France
French
pregnancy
continuity of patient care
risk factors
office visits
diagnostic techniques and procedures
pregnancy complications
risk management
preconception care
practice guideline

---
https://www.inspq.qc.ca/publications/2159
2016
false
false
false
France
French
technical report
central
risk management
hospital, nos
quebec
legionella
reticulum
bacterium, nos
hospitals
water
postphlebitic syndrome
postpoliomyelitis syndrome
legionella, nos
uterine artery embolization
water
bacteria
bacteria

---
http://www.has-sante.fr/portail/jcms/c_2019357/r/comment-reduire-les-risques-associes-a-la-creation-d-un-pneumoperitoine-en-chirurgie-digestive
http://www.has-sante.fr/portail/jcms/c_2011489/fr/ssp-comment-reduire-les-risques-associes-a-la-creation-d-un-pneumoperitoine-en-chirurgie-digestive-rapport
2016
false
false
false
France
French
scientific and technical information
pneumoperitoneum
child
adult
risk management
laparoscopy
intraoperative complications
preoperative period
postoperative complications
pneumoperitoneum
pneumoperitoneum

---
http://www.pharmactuel.com/index.php/pharmactuel/article/view/1044
2016
false
false
false
Canada
French
journal article
swiss
pharmacists
risk management
pharmacist
switzerland
pharmaceutical preparations
drug, nos
socialism

---
http://www.federationaddiction.fr/rapport-dorientation-et-recommandations-de-la-commission-daudition-publique-sur-la-rdrd/#more-26299
http://www.addictologie.org/dist/telecharges/FFA2016_RapportOrientation&Recos.pdf
2016
false
false
false
France
French
substance-related disorders
behavior, addictive
health policy guidelines
risk management

---
http://www.has-sante.fr/portail/jcms/c_2025542/fr/ce-qu-il-faut-savoir-sur-l-evaluation-de-la-demarche-qualite-et-gestion-des-risques-au-bloc-operatoire
2015
false
false
false
France
French
scientific and technical information
operating rooms
risk management
qualitative evaluation
evaluation studies as topic
gait
qualitative
gait, nos

---
http://www.assproscientifique.fr/
false
false
false
France
French
scientific society
general surgery
obstetrics
anesthesiology
risk management

---
http://www.asspro.fr/
false
false
false
France
French
association of health professionals
postoperative complications
risk management

---
Nous contacter.
16/05/2024


[Home] [Top]

© Rouen University Hospital. Any partial or total use of this material must mention the source.